Try our beta test site

Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2017 by University of California, Davis
Sponsor:
Collaborator:
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
University of California, Davis
ClinicalTrials.gov Identifier:
NCT01736943
First received: November 26, 2012
Last updated: January 19, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)